|
|
| | (5Z)-5-(2-oxo-1H-indol-3-ylidene)-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one Basic information |
| | (5Z)-5-(2-oxo-1H-indol-3-ylidene)-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one Chemical Properties |
| density | 1.51±0.1 g/cm3(Predicted) | | pka | 10.05±0.20(Predicted) | | form | Solid | | color | Brown to reddish brown |
| | (5Z)-5-(2-oxo-1H-indol-3-ylidene)-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one Usage And Synthesis |
| Description | MM01 is a novel broad-spectrum inflammasome inhibitor for the potential treatment of multifactorial diseases involving the dysregulation of multiple inflammasomes. | | Uses | ClpB-IN-1 (compound 7) is a potent ClpB inhibitor. ClpB-IN-1 is a potential antibacterial agents[1]. | | References | [1] Martin I, et, al. Screening and evaluation of small organic molecules as ClpB inhibitors and potential antimicrobials. J Med Chem. 2013 Sep 26;56(18):7177-89. DOI:10.1021/jm400499k |
| | (5Z)-5-(2-oxo-1H-indol-3-ylidene)-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-4-one Preparation Products And Raw materials |
|